New study tests simpler procedure to stop post-miscarriage bleeding
NCT ID NCT07206342
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at the best way to stop heavy bleeding after a miscarriage. It compares two procedures: one that temporarily blocks blood vessels with a gelatin material, and another that does the same but also removes tissue from the womb. About 110 participants will be followed for a year to see which method works better and how it affects future fertility.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
resorbable gelatin embolization
What this could lead to
If successful, this could establish a simpler, less invasive standard treatment for post-miscarriage bleeding, potentially preserving fertility.
What could go wrong
This is a small, early-stage trial (110 participants) comparing two procedures; one may not be clearly better, and results may not apply to all patients. Risks include bleeding recurrence or complications from the procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE, OBSTETRIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Grenoble Alpes
Grenoble, 38000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Bordeaux
Bordeaux, 33000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
CHU de Clermont-Ferrand-Gabriel Montpied
Clermont-Ferrand, 63000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de St Etienne-Hôpital Nord
Saint-Etienne, 42000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact